Exo Iris

Exo (Exo Imaging, Inc.) is a medical device company headquartered in Santa Clara, California, that builds pocket-sized ultrasound systems with embedded AI. Its aim is to replace carts and multiple probes with one handheld whole-body device for clinicians at the point of care.

Exo Iris is offered in handheld or cart form with phased, curved and linear probes. SweepAI guides probe motion, labels anatomy, captures key views and measures automatically, even offline. Exo Works handles charting, sync and billing, Exo U provides AI scan tutoring, and cardiac, lung and fluid-management AI suites add decision support. Case studies include Fort Bend County EMS and Geisinger.

• SweepAI: guides probe motion, labels anatomy, auto-captures key views and auto-measures.
• Whole-body probes: phased, curved and linear options in handheld or cart form.
• Exo Works: charting, sync and billing in a vendor-neutral workflow.
• Exo U: AI scan tutoring and anatomical labeling for training.
• AI suites: cardiac, lung, fluid management and population health tools.
• Offline mode: scanning and AI continue without network connectivity.

Emergency departments and ambulance services in Vietnam can use guided lung and cardiac scans for fast triage. District hospitals and clinics can let general practitioners perform basic scans without a sonographer. Medical schools can use Exo U for scanning training.

Replaces a cart and several probes with a single pocket-sized device. AI guidance helps novice users acquire usable views and measurements. Offline operation suits ambulances and remote sites. FDA-cleared AI tools support lung and cardiac assessment at the bedside.

Point-of-care ultrasound is moving from cart-based systems to pocket devices with AI that lowers the skill barrier for non-specialists. In Southeast Asia, shortages of sonographers and radiologists outside major cities make guided handheld scanning relevant for primary care and emergency services.

Headquartered at Santa Clara, California (address on exo.inc). Strategic partnership with Samsung Medison announced 2025-05. Named to TIME's World's Top HealthTech Companies 2026. FDA-cleared AI for pleural effusion launched 2025-06.